State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET

per Chomet, Marion, van Dongen, Guus A. M. S., Vugts, Danielle J.
Publicat a Bioconjug Chem (2021)

PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET

per van Dongen, Guus A. M. S., Poot, Alex J., Vugts, Danielle J.
Publicat 2012

The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors

per Pruis, Ilanah J., van Dongen, Guus A. M. S., Veldhuijzen van Zanten, Sophie E. M.
Publicat a Int J Mol Sci (2020)

Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe

per Heuveling, Derrek A., Karagozoglu, K. Hakki, Van Lingen, Arthur, Hoekstra, Otto S., Van Dongen, Guus A. M. S., De Bree, Remco
Publicat a EJNMMI Res (2018)

The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by (89)Zr-immuno-PET in xenograft bearing mice

per Chomet, Marion, Schreurs, Maxime, Nguyen, Margaret, Howng, Bruce, Villanueva, Ruth, Krimm, Michael, Vasiljeva, Olga, van Dongen, Guus A.M.S, Vugts, Danielle J.
Publicat a Theranostics (2020)

Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis

per Maussang, David, Verzijl, Dennis, van Walsum, Marijke, Leurs, Rob, Holl, Jens, Pleskoff, Olivier, Michel, Detlef, van Dongen, Guus A. M. S., Smit, Martine J.
Publicat 2006

An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the Pt(II) Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates

per Merkul, Eugen, Muns, Joey A., Sijbrandi, Niels J., Houthoff, Hendrik‐Jan, Nijmeijer, Bart, van Rheenen, Gerro, Reedijk, Jan, van Dongen, Guus A. M. S.
Publicat a Angew Chem Int Ed Engl (2021)

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging

per Perk, Lars R., Vosjan, Maria J. W. D., Visser, Gerard W. M., Budde, Marianne, Jurek, Paul, Kiefer, Garry E., van Dongen, Guus A. M. S.
Publicat 2009

Performance of (89)Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma

per Jauw, Yvonne W. S., Zijlstra, Josée M., de Jong, Daphne, Vugts, Danielle J., Zweegman, Sonja, Hoekstra, Otto S., van Dongen, Guus A. M. S., Huisman, Marc C.
Publicat a PLoS One (2017)

Development of [(11)C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts

per Slobbe, Paul, Windhorst, Albert D., Adamzek, Kevin, Bolijn, Marije, Schuit, Robert C., Heideman, Daniëlle A.M., van Dongen, Guus A.M.S., Poot, Alex J.
Publicat a Oncotarget (2017)

High resolution combined molecular and structural optical imaging of colorectal cancer in a xenograft mouse model

per Feroldi, Fabio, Verlaan, Mariska, Knaus, Helene, Davidoiu, Valentina, Vugts, Danielle J., van Dongen, Guus A. M. S., Molthoff, Carla F. M., de Boer, Johannes F.
Publicat a Biomed Opt Express (2018)

ImmunoPET Imaging of Renal Cell Carcinoma with (124)I- and (89)Zr-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice

per Stillebroer, Alexander B., Franssen, Gerben M., Mulders, Peter F.A., Oyen, Wim J.G., van Dongen, Guus A.M.S., Laverman, Peter, Oosterwijk, Egbert, Boerman, Otto C.
Publicat 2013

A comparative PET imaging study with the reversible and irreversible EGFR tyrosine kinase inhibitors [(11)C]erlotinib and [(18)F]afatinib in lung cancer-bearing mice

per Slobbe, Paul, Windhorst, Albert D, Stigter-van Walsum, Marijke, Smit, Egbert F, Niessen, Heiko G, Solca, Flavio, Stehle, Gerd, van Dongen, Guus A M S, Poot, Alex J
Publicat a EJNMMI Res (2015)

Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlab...

per Muylle, Kristoff, Flamen, Patrick, Vugts, Danielle J., Guiot, Thomas, Ghanem, Ghanem, Meuleman, Nathalie, Bourgeois, Pierre, Vanderlinden, Bruno, van Dongen, Guus A. M. S., Everaert, Hendrik, Vaes, Mélanie, Bron, Dominique
Publicat a Eur J Nucl Med Mol Imaging (2015)

Biodistribution, radiation dosimetry and scouting of (90)Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin’s lymphoma using (89)Zr-ibritumomab tiuxetan an...

per Rizvi, Saiyada N. F., Visser, Otto J., Vosjan, Maria J. W. D., van Lingen, Arthur, Hoekstra, Otto S., Zijlstra, Josée M., Huijgens, Peter C., van Dongen, Guus A. M. S., Lubberink, Mark
Publicat 2012

Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?

per Jauw, Yvonne W. S., Menke-van der Houven van Oordt, C. Willemien, Hoekstra, Otto S., Hendrikse, N. Harry, Vugts, Danielle J., Zijlstra, Josée M., Huisman, Marc C., van Dongen, Guus A. M. S.
Publicat a Front Pharmacol (2016)

Facile labelling of an anti-epidermal growth factor receptor Nanobody with (68)Ga via a novel bifunctional desferal chelate for immuno-PET

per Vosjan, Maria J. W. D., Perk, Lars R., Roovers, Rob C., Visser, Gerard W. M., Stigter-van Walsum, Marijke, van Bergen en Henegouwen, Paul M. P., van Dongen, Guus A. M. S.
Publicat 2011

(124)I-L19-SIP for immuno-PET imaging of tumour vasculature and guidance of (131)I-L19-SIP radioimmunotherapy

per Tijink, Bernard M., Perk, Lars R., Budde, Marianne, Stigter-van Walsum, Marijke, Visser, Gerard W. M., Kloet, Reina W., Dinkelborg, Ludger M., Leemans, C. René, Neri, Dario, van Dongen, Guus A. M. S.
Publicat 2009

Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101)

per Gaillard, Pieter J., Appeldoorn, Chantal C. M., Dorland, Rick, van Kregten, Joan, Manca, Francesca, Vugts, Danielle J., Windhorst, Bert, van Dongen, Guus A. M. S., de Vries, Helga E., Maussang, David, van Tellingen, Olaf
Publicat 2014

Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for (89)Zr-immuno-PET

per Vugts, Danielle J., Klaver, Chris, Sewing, Claudia, Poot, Alex J., Adamzek, Kevin, Huegli, Seraina, Mari, Cristina, Visser, Gerard W. M., Valverde, Ibai E., Gasser, Gilles, Mindt, Thomas L., van Dongen, Guus A. M. S.
Publicat a Eur J Nucl Med Mol Imaging (2016)